Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2020.03.027 ◽

2020 ◽

Vol 26 (8) ◽

pp. e198-e201

Author(s):

Joseph E. Maakaron ◽

Christina Liscynesky ◽

Zeinab El Boghdadly ◽

Ying Huang ◽

Akwasi Agyeman ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Second Look ◽

Fluoroquinolone Prophylaxis

Download Full-text

Comparison of the rates ofClostridium difficileand bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation

Transplant Infectious Disease ◽

10.1111/tid.12715 ◽

2017 ◽

Vol 19 (4) ◽

pp. e12715 ◽

Author(s):

Karin Koseck ◽

Amir Steinberg ◽

Gina Caliendo ◽

Joanne Meyer ◽

Sara S. Kim

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Fluoroquinolone Prophylaxis

Download Full-text

Cancer Research Highlights: High-Dose Chemo Plus Autologous Stem Cell Transplantation Boosts Event-Free Survival in Some Patients with Aggressive NHL

PsycEXTRA Dataset ◽

10.1037/e364142004-008 ◽

2004 ◽

Author(s):

Keyword(s):

Cancer Research ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

High Dose ◽

Event Free Survival ◽

Download Full-text

Decision letter for "Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels"

10.1002/hon.2774/v2/decision1 ◽

2020 ◽

Keyword(s):

Vitamin D ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Download Full-text

Review for "Rescue of chemorefractory classical Hodgkin lymphoma with Nivolumab and autologous stem‐cell transplantation: real‐life experience"

10.1002/hon.2796/v2/review1 ◽

2020 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Life Experience ◽

Real Life ◽

Classical Hodgkin Lymphoma

Download Full-text

Decision letter for "Rescue of chemorefractory classical Hodgkin lymphoma with Nivolumab and autologous stem‐cell transplantation: real‐life experience"

10.1002/hon.2796/v2/decision1 ◽

2020 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Life Experience ◽

Real Life ◽

Classical Hodgkin Lymphoma

Download Full-text

Decision letter for "Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era"

10.1002/hon.2713/v1/decision1 ◽

2019 ◽

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Follicular Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Clinical Characteristics

Download Full-text

Faculty Opinions recommendation of Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108297.564322 ◽

2008 ◽

Author(s):

Xavier Leleu

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Plasma Cell ◽

Plasma Cell Disorders

Download Full-text

Faculty Opinions recommendation of A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995302.793474247 ◽

2013 ◽

Author(s):

Nelson Chao

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase 1 ◽

Download Full-text

Faculty Opinions recommendation of Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725403083.793507191 ◽

2015 ◽

Author(s):

Greg Bociek

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Brentuximab Vedotin ◽

Consolidation Therapy ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Risk Of Relapse

Download Full-text

Faculty Opinions recommendation of Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727170548.793548360 ◽

2018 ◽

Author(s):

Leo Gordon

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Mantle Cell Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Cell Lymphoma ◽

Molecular Monitoring ◽

Download Full-text